From Experimental 3D Printing to Production-Ready Medical Devices
Volumetric 3D printing is an additive manufacturing approach that solidifies entire three-dimensional volumes of photosensitive material at once, rather than building objects layer by layer, which enables faster fabrication of complex, clinically useful geometries and supports the production of patient-specific medical devices at scale. This shift is changing how medical device production is planned and delivered. Instead of slow, single-off prototypes, clinicians and manufacturers now look at 3D printing as a way to supply repeatable devices with consistent quality. At the same time, maturing biofabrication ecosystems for volumetric bioprinting and organoid scaffolds show that complex biological structures can be manufactured more reliably. Together with new workflows for 3D printed prosthetics and custom insoles manufacturing, the technology is moving from research labs into routine clinical practice, indicating that additive manufacturing is becoming part of mainstream healthcare infrastructure.
Hologram-Guided Volumetric 3D Printing Speeds Up Clinical-Scale Parts
Recent work in tomographic volumetric additive manufacturing (TVAM) shows how holograms can sharpen both speed and accuracy for medical device production. Researchers at EPFL’s Laboratory of Applied Photonic Devices built a platform that encodes 3D forms in holograms and controls the phase of laser light to cure a rotating vial of resin into solid parts. By modulating alignment instead of brightness, their method preserves more laser power and supports self-healing beams, which perform better in light‑scattering, cell‑laden media. They report that the system can solidify millimeter‑scale objects in a few seconds and centimeter‑scale objects in minutes, while maintaining high fidelity. According to Christophe Moser, the head of LAPD, “Our method’s demonstrated efficiency and precision finally makes it possible to bioprint tissue-like structures at near-clinical scale.” This kind of volumetric 3D printing platform directly targets biomedical components, rather than generic prototypes.
Custom Insoles Manufacturing Moves to the Smartphone
Footcare brand Superfeet is showing how 3D printing can support mass personalization through its ME3D platform for custom insoles manufacturing. Customers can now scan their feet with an iPhone on the company’s website and send that biometric data straight to a dedicated 3D printing facility. A podiatry-informed algorithm interprets the scan, builds a detailed model of each foot, and generates a tailored insole design. Users see a 3D rendering, review arch height and shoe size recommendations, choose between two performance foam options, and even add engraving before ordering. According to Trip Randall, CEO of Superfeet, this evolution “allows us to deliver a level of individualized engineering that was once only possible through specialized in-person experiences.” The result is a reproducible, digital pipeline from home scan to industrial 3D printing, turning what used to be a niche clinical service into a scalable consumer health product.
3D Printed Prosthetics Edge Toward Everyday Clinical Use
Alongside orthotic insoles, 3D printed prosthetics are maturing from low-cost experiments into structured systems designed for daily wear. Modular, printable prosthetic platforms now aim to restore user autonomy by combining lightweight structures, adjustable components, and accessible manufacturing. Digital workflows allow clinicians or technicians to scan a residual limb, adapt modular designs, and send files to print without long waits for traditional fabrication. This approach can help standardize quality while leaving room for personalization in fit and function. Because components are digitally defined, replacements and upgrades can be produced on demand without rebuilding an entire device. As these systems align more closely with clinical requirements for durability, comfort, and safety testing, they highlight 3D printing’s movement from one-off charity projects to integrated medical device production. The same principles that support volumetric 3D printing of complex shapes are now informing how prosthetic parts are designed for strength and precision.
A Broader Biofabrication Ecosystem Points to the Next Phase
The rise of volumetric 3D printing in medicine is reinforced by a growing biofabrication ecosystem around materials, processes, and support infrastructure. Distribution partnerships for bioinks that support volumetric bioprinting expand access to photosensitive, cell-compatible materials tuned for different printing methods, from extrusion and DLP to advanced volumetric setups. In parallel, researchers are using 3D printing to create scaffolding trays that help grow larger, more complex human organoids, pointing toward future applications in drug testing and regenerative medicine. These developments sit alongside more traditional industrial additive manufacturing, such as metal and ceramic printing, but are focused on living or biologically relevant structures. As bioinks, hardware, and clinical workflows start to align, volumetric 3D printing, 3D printed prosthetics, and custom insoles are no longer isolated innovations. Together, they mark a shift toward on-demand, patient-centered medical device production that can scale within real healthcare systems.
